Renishaw Drug Delivery System

DEVICE3 trials

Sponsors

Herantis Pharma Plc., Renishaw

Conditions

Brain DiseasesMovement DisordersNervous System DiseasesNeuro-Degenerative DiseaseNeurodegenerative DiseasesParkinson Disease

Phase 1

Clinical Study to Test the Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease

CompletedNCT03295786

Herantis Pharma Plc.Brain Diseases, Movement Disorders, Nervous System Diseases +2

Start: 2017-09-26End: 2019-12-19Updated: 2020-01-13

Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease. Extension to HP-CD-CL-2002 Clinical Study

CompletedNCT03775538

Herantis Pharma Plc.Brain Diseases, Movement Disorders, Nervous System Diseases +2

Start: 2018-07-05End: 2020-07-08Updated: 2020-08-12

Long-Term Follow-up Safety After DDS Implantation With/Without CDNF Infusions

RenishawBrain Diseases, Movement Disorders, Nervous System Diseases +2

Start: 2019-03-20End: 2023-03-20Updated: 2021-03-23